Trial Profile
Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection: a Non-Inferiority Trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Amoxicillin/clavulanic acid; Cotrimoxazole; Nitrofurantoin
- Indications Overactive bladder; Urinary tract infections
- Focus Adverse reactions
- 31 Oct 2023 Status has been changed to discontinued.
- 05 Aug 2021 Planned End Date changed from 1 Sep 2021 to 1 Sep 2022.
- 05 Aug 2021 Planned primary completion date changed from 1 Jun 2021 to 1 Jun 2022.